Detalhe da pesquisa
1.
Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative study.
Haematologica
; 106(12): 3100-3106, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047178
2.
[Very Severe Differentiation Syndrome in Low Risk Acute Promyelocytic Leukemia - A Peril of Differentiating Therapy]. / Sehr schweres Differenzierungssyndrom bei Niedrigrisiko akuter Promyelozytenleukämie eine Tücke der differenzierenden Therapie.
Dtsch Med Wochenschr
; 142(2): 111-114, 2017 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-28114716